Cormorant Asset Management’s Kite Pharma, Inc. KITE Stock Holding History

Cormorant Asset Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-68,800	Closed	-$3.16M	–	94
2016 Q1	$3.16M	Hold	68,800	–	–	0.48%	52
2015 Q4	$4.24M	Hold	68,800	–	–	0.51%	48
2015 Q3	$3.83M	Hold	68,800	–	–	0.61%	45
2015 Q2	$4.2M	Sell	68,800 -31,200	-31%	-$1.78M	0.56%	44
2015 Q1	$5.77M	Sell	100,000 -155,000	-61%	-$10.4M	0.89%	38
2014 Q4	$14.7M	Buy	255,000 +155,000	+155%	+$6.53M	2.27%	15
2014 Q3	$2.85M	Buy	+100,000	New	+$2.47M	0.59%	43

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Cormorant Asset Management's KITE Position: Q2 2016 in Review

Cormorant Asset Management sold out of Kite Pharma, Inc. (KITE) in Q2 2016, closing a stake of 68,800 shares — an estimated $3.16M sold.

Cormorant Asset Management first reported a position in KITE in Q3 2014 and held it in 7 quarters. The position peaked at $14.7M in Q4 2014. 173 funds tracked by Wall St. Rank hold KITE as of Q2 2016.

Cormorant Asset Management reported no remaining Kite Pharma, Inc. position as of Q2 2016 after selling out during the quarter.
Cormorant Asset Management sold 68,800 Kite Pharma, Inc. shares in Q2 2016, an estimated $3.16M.
Cormorant Asset Management first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 7 quarters.
Cormorant Asset Management's Kite Pharma, Inc. position peaked at $14.7M in Q4 2014.
173 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q2 2016.

Based on Cormorant Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.